Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

about

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q47671753

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

@en

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

@nl

type

Item

label

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

@en

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

@nl

prefLabel

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

@en

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

@nl

P1476

Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

@en

P2093

Carol-Immanuel Geppert

http://www.w3.org/2001/XMLSchema#string

Denis Iulian Trufa

http://www.w3.org/2001/XMLSchema#string

Horia Sirbu

http://www.w3.org/2001/XMLSchema#string

Juliane Friedrich

http://www.w3.org/2001/XMLSchema#string

Julius Malte Vahl

http://www.w3.org/2001/XMLSchema#string

Katerina Kachler

http://www.w3.org/2001/XMLSchema#string

Lisanne Heim

http://www.w3.org/2001/XMLSchema#string

Liubov Balabko

http://www.w3.org/2001/XMLSchema#string

Nicole Fuhrich

http://www.w3.org/2001/XMLSchema#string

Nina Sopel

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

T cell exhaustion

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report.

Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.

TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression

Current status of interleukin-10 and regulatory T-cells in cancer

Nivolumab in NSCLC: latest evidence and clinical potential

P2888

bjc.2017.336

P304

1644-1655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2017.336

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092152707

http://www.w3.org/2001/XMLSchema#string

P698

29016555

http://www.w3.org/2001/XMLSchema#string

P932

5729436

http://www.w3.org/2001/XMLSchema#string